LMH STRATEGIC SOLUTIONS

LMH STRATEGIC SOLUTIONS filed a Q1 termination report for TRAVERE THERAPEUTICS, INC. on April 17, 2026, reporting no lobbying activity.

Lobbying for TRAVERE THERAPEUTICS, INC. · Biopharmaceutical company.

Filing · LD-2 quarterly report Q1 terminationNo activity

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Representation ended

Jan 1, 2026

The registrant reported terminating its work for this client.

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.